Results 121 to 130 of about 8,289 (149)
When Atypical Becomes Typical: A Fulminant Seronegative Anti-GBM Disease. [PDF]
Andrawes-Barbara FY +4 more
europepmc +1 more source
Urinary cell cycle arrest biomarkers TIMP-2 and IGFBP7 for the assessment of acute kidney injury in dogs with pyometra. [PDF]
Braz LADN +8 more
europepmc +1 more source
Histologic Resolution of Proliferative Glomerulonephritis with Monoclonal Ig Deposits. [PDF]
Abdalla MS, Hogan MC, Leung N, Nasr SH.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Familial membranoproliferative glomerulonephritis
Nephrology Dialysis Transplantation, 1995Abstract Four and two male sibs of two separate families who had biopsy-proven membranoproliferative glomerulonephritis (MPGN) are presented. In the first family four sibs of the first-degree consanguineous marriage showed the clinical picture of nephrotic syndrome without hypocomplementaemia at initial laboratory findings.
A, Bakkaloglu +4 more
openaire +2 more sources
Idiopathic Membranoproliferative Glomerulonephritis
Annual Review of Medicine, 1980Idiopathic membranoproliferative glomerulonephritis (MPGN) is one iden tifiable form of chronic nephritis characterized by distinctive glomerular morphology. However, it is not known whether MPGN is a single patho genetic entity. It was originally recognized as one type of chronic glomerulonephritis with persistent hypocomplementemia by West et al (1)
Y, Kim, A F, Michael
openaire +2 more sources
Membranoproliferative Glomerulonephritis in Pregnancy
The American Journal of the Medical Sciences, 2017Membranoproliferative glomerulonephritis (MPGN) is an uncommon form of glomerulonephritis and it can be particularly difficult to predict outcomes and manage women with this disorder during pregnancy.The management of 3 successful pregnancies in women with MPGN from 1 center and previously described cases from the world literature are reviewed.
Devika, Nair +2 more
openaire +2 more sources
Immunosuppressive Treatment of Membranoproliferative Glomerulonephritis
Nephron, 2008The treatment of membranoproliferative glomerulonephritis (MPGN) is considered by most authors as unrewarding, and the disease progresses to end-stage renal disease (ESRD). We studied the effectiveness of a new immunosuppressive (IS) regimen by analyzing the rates of remission, relapse and progression to ESRD in 19 patients with MPGN.
FAEDDA R +4 more
openaire +5 more sources
Membranoproliferative glomerulonephritis and amyloidosis
Human Pathology, 1984The first known case of membranoproliferative glomerulonephritis co-existing with amyloidosis is reported. The question of whether the amyloidosis was secondary to the glomerulonephritis or whether primary amyloidosis co-existed with membranoproliferative glomerulonephritis is addressed.
openaire +2 more sources

